View in EDS

Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.

Saved in:

Bibliographic Details
Title:	Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
Authors:	Spratt DE; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio., George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina., Shore ND; Carolina Urologic Research Center and GenesisCare USA, Myrtle Beach, South Carolina., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City., Saltzstein DR; Urology San Antonio, San Antonio, Texas., Tutrone R; Chesapeake Urology, Towson, Maryland., Bossi A; Department of Radiation Oncology, Gustave Roussy Cancer Institute, Villejuif, France., Brown BA; Myovant Sciences Inc, Brisbane, California., Lu S; Myovant Sciences Inc, Brisbane, California., Fallick M; Myovant Sciences Inc, Brisbane, California., Hanson S; Pfizer Inc, New York, New York., Tombal BF; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium.
Source:	JAMA oncology [JAMA Oncol] 2024 May 01; Vol. 10 (5), pp. 594-602.
Publication Type:	Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2374-2445
DOI:	10.1001/jamaoncol.2023.7279